Literature DB >> 28431036

Effects of Delay Duration on the WMS Logical Memory Performance of Older Adults with Probable Alzheimer's Disease, Probable Vascular Dementia, and Normal Cognition.

Valencia Montgomery1, Katie Harris1, Anthony Stabler1, Lisa H Lu1.   

Abstract

OBJECTIVE: To examine how the duration of time delay between Wechsler Memory Scale (WMS) Logical Memory I and Logical Memory II (LM) affected participants' recall performance.
METHOD: There are 46,146 total Logical Memory administrations to participants diagnosed with either Alzheimer's disease (AD), vascular dementia (VaD), or normal cognition in the National Alzheimer's Disease Coordinating Center's Uniform Data Set.
RESULTS: Only 50% of the sample was administered the standard 20-35 min of delay as specified by WMS-R and WMS-III. We found a significant effect of delay time duration on proportion of information retained for the VaD group compared to its control group, which remained after adding LMI raw score as a covariate. There was poorer retention of information with longer delay for this group. This association was not as strong for the AD and cognitively normal groups. A 24.5-min delay was most optimal for differentiating AD from VaD participants (47.7% classification accuracy), an 18.5-min delay was most optimal for differentiating AD versus normal participants (51.7% classification accuracy), and a 22.5-min delay was most optimal for differentiating VaD versus normal participants (52.9% classification accuracy).
CONCLUSIONS: Considering diagnostic implications, our findings suggest that test administration should incorporate precise tracking of delay periods. We recommend a 20-min delay with 18-25-min range. Poor classification accuracy based on LM data alone is a reminder that story memory performance is only one piece of data that contributes to complex clinical decisions. However, strict adherence to the recommended range yields optimal data for diagnostic decisions.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Non-standard test administration; Sensitivity; Specificity; Training

Mesh:

Year:  2017        PMID: 28431036      PMCID: PMC5400025          DOI: 10.1093/arclin/acx005

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  10 in total

Review 1.  The neuropsychological profile of Alzheimer disease.

Authors:  Sandra Weintraub; Alissa H Wicklund; David P Salmon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

2.  Self-monitoring enhances Wisconsin Card Sorting Test performance in patients with schizophrenia: performance is improved by simply asking patients to verbalize their sorting strategy.

Authors:  W Perry; E G Potterat; D L Braff
Journal:  J Int Neuropsychol Soc       Date:  2001-03       Impact factor: 2.892

3.  Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia.

Authors:  M C Tierney; S E Black; J P Szalai; W G Snow; R H Fisher; G Nadon; H C Chui
Journal:  Arch Neurol       Date:  2001-10

4.  Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.

Authors:  Bruce R Reed; Dan M Mungas; Joel H Kramer; William Ellis; Harry V Vinters; Chris Zarow; William J Jagust; Helena C Chui
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

Review 5.  The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit?

Authors:  David W Desmond
Journal:  J Neurol Sci       Date:  2004-11-15       Impact factor: 3.181

Review 6.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

7.  Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA Division 40 members.

Authors:  Laura A Rabin; William B Barr; Leslie A Burton
Journal:  Arch Clin Neuropsychol       Date:  2005-01       Impact factor: 2.813

8.  Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Sharon X Xie; David J Libon; Xingmei Wang; Lauren Massimo; Peachie Moore; Luisa Vesely; Alea Khan; Anjan Chatterjee; H Branch Coslett; Howard I Hurtig; Tsao-Wei Liang; Murray Grossman
Journal:  J Int Neuropsychol Soc       Date:  2009-12-11       Impact factor: 2.892

Review 9.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.

Authors:  Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

10.  Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia.

Authors:  N L Graham; T Emery; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

  10 in total
  1 in total

1.  A Deep Learning Approach for Automated Diagnosis and Multi-Class Classification of Alzheimer's Disease Stages Using Resting-State fMRI and Residual Neural Networks.

Authors:  Farheen Ramzan; Muhammad Usman Ghani Khan; Asim Rehmat; Sajid Iqbal; Tanzila Saba; Amjad Rehman; Zahid Mehmood
Journal:  J Med Syst       Date:  2019-12-18       Impact factor: 4.460

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.